table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comers
COVID 19 hospitalizedCOVID 19 all comers
janus kinase (JAK) inhibitor
baricitinib ACTT-2 ... COV-BARRIER RECOVERY
tofacitinib STOP-COVID ...

0 studies excluded by filtering options 0

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons